Contents
Download PDF
pdf Download XML
210 Views
99 Downloads
Share this article
Research Article | Volume 13 Issue:2 (, 2023) | Pages 478 - 485
A prospective study on ovarian tumour with histological corelation and CA125, HE4 level attertiary care canter of central India
Under a Creative Commons license
Open Access
DOI : 10.5083/ejcm
Published
May 1, 2023
Abstract

Introduction- Ovarian cancer is one of the ten most commonly diagnosed cancers in women and has the highest mortality rate and the worst prognosis of all gynecological cancers. In 2018, 295,414 cases of Ovarian cancer were detected worldwide, and 184,799 died, with the highest incidence in developed countries. The mortality rate has not changed in the past 30 years, and it is predicted that by 2040, this rate will be significantly increasing. Materials And Methods- Study based on proper clinical examination, radiological investigation, histopathological diagnosis and hematological investigations and Measurement of serum CA-125 and HE4 will be carried out by ELISA method. Results- out of 50 neoplastic lesions 31 cases are benign tumours, 02Borderline and 17 cases are malignant. Conclusion-We concluded High ROMA Index Value shows malignancy. Low value of ROMA index cases are benign so that ROMA Index is helpful to differentiate     in benign and malignant lesion preoperatively

Keywords
Recommended Articles
Research Article
Lipid Profile Analysis in Chronic Alcoholic Patients: An Observational Study in A Tertiary Care Hospital
...
Published: 22/08/2025
Download PDF
Research Article
Effect of OM meditation on cardiovascular parameters
...
Published: 22/08/2025
Download PDF
Research Article
Study of Electrocardiography and 2d Echocardiography in Patients with Left Ventricular Hypertrophy
...
Published: 22/08/2025
Download PDF
Research Article
Endotracheal Size Estimation in Children: What is Latest? Different Methods and Correlation – A Prospective Observational Study
...
Published: 22/08/2025
Download PDF
Chat on WhatsApp
Copyright © EJCM Publisher. All Rights Reserved.